• 16 The burden of cancer overdiagnosis in Australia 

      Glasziou, Paul; Jones, Mark; Pathirana, Thanya; Barratt, Alexandra L; Bell, Katy J.L.
      Published 2019
      Burden of cancer is increasing worldwide, and in Australia, partly due to overdiagnosis: cancers which would never cause symptoms or harm if left undetected. We sought to estimate the current burden of overdiagnosis of ...
      Presentation
    • ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial 

      Denholm, Justin T; Venkatesh, Balasubramanian; Davis, Joshua; Bowen, Asha C.; Hammond, Naomi E; Jha, Vivekanand; McPhee, Grace; McQuilten, Zoe; O'Sullivan, Matthew VN; Paterson, David; Price, David; Rees, Megan; Roberts, Jason; Jones, Mark; Totterdell, James; Snelling, Thomas; Trask, Nanette; Morpeth, Susan; Tong, Steven YC
      Published 2022
      Background SARS-CoV-2 infection is associated with a significant risk of hospitalisation, death, and prolonged impact on quality of life. Evaluation of new treatment options and optimising therapeutic management of people ...
      Preprint
    • Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial 

      Hockham, Carinna; Kotwal, Sradha; Wilcox, Arlen; Bassi, Abhinav; McGree, James; Pollock, Carol; Burrell, Louise M.; Bathla, Nikita; Kunigari, Mallikarjuna; Rathore, Vinay; John, Michael; Lin, Enmoore; Jenkins, Christine; Ritchie, Angus; McLachlan, Andrew; Snelling, Thomas; Jones, Mark; Jha, Vivekanand; Jardine, Meg;
      Published 2021
      BackgroundSARS-CoV-2 binds to membrane-bound angiotensin-converting enzyme 2 (ACE2) which may result in downregulation of membrane-bound ACE2. ACE2 is a key regulator of the renin-angiotensin system (RAS) and is responsible ...
      Article